[
  {
    "ts": null,
    "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of January 5",
    "summary": "Stay up to date on dividend activity with our weekly summary for Dividend Champions, Contenders, and Challengers, including ex-dividend and pay dates.",
    "url": "https://finnhub.io/api/news?id=d6d78b22ca7105fa42186fc7284c7195c78675278deb671f8e29314e0c0c3f19",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735948145,
      "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of January 5",
      "id": 132263103,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Stay up to date on dividend activity with our weekly summary for Dividend Champions, Contenders, and Challengers, including ex-dividend and pay dates.",
      "url": "https://finnhub.io/api/news?id=d6d78b22ca7105fa42186fc7284c7195c78675278deb671f8e29314e0c0c3f19"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co. Inc. stock underperforms Friday when compared to competitors",
    "summary": "Merck & Co. Inc. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=a6b08a10b4c91ba0bb4eb7ec68a6f3778a830b04d31f5406d4048180e1ff0141",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735922100,
      "headline": "Merck & Co. Inc. stock underperforms Friday when compared to competitors",
      "id": 132322279,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Merck & Co. Inc. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=a6b08a10b4c91ba0bb4eb7ec68a6f3778a830b04d31f5406d4048180e1ff0141"
    }
  },
  {
    "ts": null,
    "headline": "Moderna: From Breakthrough COVID-19 Vaccines To Personalized Cancer Therapies",
    "summary": "Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors. See why MRNA stock is a Buy.",
    "url": "https://finnhub.io/api/news?id=ce76b57837faee58c95619bf41c38523478a64b559f1efd0b19d97a17640eb4b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735874956,
      "headline": "Moderna: From Breakthrough COVID-19 Vaccines To Personalized Cancer Therapies",
      "id": 132248512,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1284796611/image_1284796611.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors. See why MRNA stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=ce76b57837faee58c95619bf41c38523478a64b559f1efd0b19d97a17640eb4b"
    }
  }
]